Cimetidine enhancement of cyclophosphamide antitumour activity.

por Dorr, R. T., Alberts, D. S.
Publicado 1982

Rubidazone vs adriamycin: an evaluation of their differential toxicity in the spleen colony assay system.

por Alberts, D. S., Van Daalen Wetters, T.
Publicado 1976

Comparison of assays used for in vitro chemosensitivity testing of human tumours.

por Salmon, S. E., Meyskens, F. L., Alberts, D. S.
Publicado 1984

Promising agents for chemoprevention of skin cancer

por Stratton, S.P., Stratton, M.S., Alberts, D.S.
Publicado 2006

Effect of phenobarbital on plasma levels of cyclophosphamide and its metabolites in the mouse.

por Alberts, D. S., Peng, Y. M., Chen, H. S., Struck, R. F.
Publicado 1978

Effect of renal dysfunction in dogs on the disposition and marrow toxicity of melphalan.

por Alberts, D. S., Chen, H. G., Benz, D., Mason, N. L.
Publicado 1981

Inhibition of human tumour clonogenicity by chlorambucil and its metabolites.

por Goodman, G. E., McLean, A., Alberts, D. S., Chang, S. Y.
Publicado 1982

Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administration.

por Peng, Y. M., Alberts, D. S., Chen, H. S., Mason, N., Moon, T. E.
Publicado 1980

Expression of the zinc finger gene EVI-1 in ovarian and other cancers.

por Brooks, D. J., Woodward, S., Thompson, F. H., Dos Santos, B., Russell, M., Yang, J. M., Guan, X. Y., Trent, J., Alberts, D. S., Taetle, R.
Publicado 1996

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.

por Aabo, K., Adams, M., Adnitt, P., Alberts, D. S., Athanazziou, A., Barley, V., Bell, D. R., Bianchi, U., Bolis, G., Brady, M. F., Brodovsky, H. S., Bruckner, H., Buyse, M., Canetta, R., Chylak, V., Cohen, C. J., Colombo, N., Conte, P. F., Crowther, D., Edmonson, J. H., Gennatas, C., Gilbey, E., Gore, M., Guthrie, D., Yeap, B. Y.
Publicado 1998